Prof. Dr. Holger Erfle studied physics and did his PhD at Heidelberg University. He worked for more than 20 years as a scientist at the EMBL in Heidelberg. Since 2007, he has headed the “Advanced Biological Screening Facility” (ABSF) and the “HiCell” research group at BioQuant. His main interest is the design and development of novel technologies for high-throughput and high-content screening.